Legal & General Group PLC Rallybio Corp Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.31 - $8.89 $2,456 - $5,067	570 Added 23.99%	2,946 $16,000
Q4 2022 Feb 14, 2023	BUY	$4.67 - $14.86 $2,591 - $8,247	555 Added 30.48%	2,376 $15,000
Q3 2022 Nov 14, 2022	BUY	$7.54 - $14.56 $557 - $1,077	74 Added 4.24%	1,821 $26,000
Q1 2022 May 16, 2022	BUY	$6.91 - $15.04 $7,497 - $16,318	1,085 Added 163.9%	1,747 $12,000
Q3 2021 Nov 15, 2021	BUY	$10.83 - $23.4 $7,169 - $15,490	662 New	662 $12,000

31.9M

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $31.8M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.